A safe algorithm for MGIT positives with contamination flags
A positive signal from a mycobacterial growth indicator tube (MGIT) is a significant laboratory event, but it is not automatically a confirmed diagnosis of tuberculosis. A contamination flag may indicate bacterial or fungal overgrowth, a mixed culture, an instrument issue, or a specimen-processing problem. The reading and reporting pathway must therefore protect staff, preserve the isolate where possible, and give clinicians a clear statement of what is known.
For Australian laboratories, the algorithm should fit the local referral network, test menu and quality management system. A metropolitan service in Sydney or Melbourne may have rapid access to a state or territory reference laboratory, while a regional laboratory in Western Australia or Queensland may need to arrange overnight transport. Written decision points help both settings produce consistent results and avoid premature reporting of Mycobacterium tuberculosis complex.
Define the result before interpreting the flag
The first step is to capture the complete instrument event: specimen number, tube type, date and time loaded, date and time flagged positive, instrument position, operator, and any warning code. A positive MGIT signal with a contamination or quality flag should remain in a controlled workflow until microscopy and contamination checks are completed. Staff should not treat the instrument alarm as an organism identification.
Review the specimen history at the same time. Record whether it was sputum, bronchoalveolar lavage, tissue, urine or another material; whether decontamination was performed; and whether the specimen was scant, bloody or delayed in transit. Check that the tube was labelled correctly and that the associated primary specimen, smear result and molecular test results are available.
The algorithm should define an immediate safety category. A tube that is visibly leaking, pressurised, broken or associated with an aerosol-generating incident requires incident management and containment before routine work continues. Centrifugation, vortexing and opening culture tubes should follow the laboratory’s biosafety risk assessment and local procedures. A practical centrifuge safety procedure can support this part of the quality system.
Use microscopy and subculture to classify growth
When a flagged tube is safe to examine, perform the laboratory-approved acid-fast smear and a contamination check. An acid-fast bacilli smear supports the presence of mycobacteria, but it does not distinguish M. tuberculosis complex from non-tuberculous mycobacteria (NTM). A negative smear does not invalidate a positive MGIT signal, particularly when the organism burden is low or the signal is early.
A Gram stain and suitable subculture can help identify ordinary bacterial or fungal contamination. Rapid, heavy growth on routine media, mixed colony types, turbidity and a non-specific Gram-stain pattern are warning signs. A positive acid-fast smear with concurrent bacterial growth may represent a mixed culture rather than a simple contaminated tube. The isolate should be retained or referred according to the laboratory’s validated procedure.
The algorithm can assign one of several working classifications:
- positive MGIT with acid-fast bacilli detected and no obvious contamination;
- positive MGIT with suspected bacterial or fungal contamination;
- positive MGIT with mixed growth or inconclusive microscopy;
- positive MGIT with no acid-fast bacilli detected; or
- instrument or process failure requiring repeat testing or referral.
Each classification needs a defined next action, responsible role and maximum reporting time. “Contaminated” should not be used as a final interpretation when clinically important mycobacterial growth may still be recoverable. If a specimen is high priority, the laboratory should promptly discuss additional processing or referral with the treating service and public health contact.
Confirm tuberculosis before issuing a definitive report
A preliminary report should separate the culture signal from the organism identification. For example, “Mycobacterial growth detected; identification in progress” is more accurate than “TB positive” when only the MGIT instrument and microscopy have been assessed. If contamination prevents reliable identification, the report should state that the culture is contaminated or uninterpretable and explain whether repeat specimen collection or referral is recommended.
Use a validated rapid identification method for M. tuberculosis complex and NTM, such as an approved nucleic acid amplification test, line-probe method, matrix-assisted laser desorption/ionisation approach, or reference-laboratory testing. The selected method must be appropriate to the specimen and validated for the relevant culture matrix. A molecular result should be interpreted with smear findings, clinical information and the possibility of mixed culture.
A confirmed or strongly suspected M. tuberculosis complex result is urgent. The laboratory should follow Australian state or territory notification requirements, communicate promptly with the requesting clinician and activate the established pathway for drug susceptibility testing. Results that may affect isolation, contact investigation or treatment should be telephoned or transmitted through an approved secure channel, with the time, recipient and message documented.
For an NTM result, report the identification and indicate that clinical significance requires correlation with symptoms, imaging and repeated microbiological evidence. Avoid equating every NTM-positive culture with disease. If resistance testing, sequencing or a definitive species-level identification is outside the local capability, refer the isolate through the relevant Australian reference service.
Make contamination a quality signal
Contamination rates should be monitored by specimen type, collection site, ward, referring service, decontamination batch, operator and time period. A sudden increase in contaminated MGIT tubes from one hospital may indicate collection technique, transport delay or leakage in a specimen container. A cluster from a single processing run may point to reagent preparation, cabinet cleaning, centrifuge handling or cross-contamination.
Set locally justified alert limits and review them at defined intervals. The review should include rejected specimens, repeat collections, false-positive signals, instrument maintenance, control results and corrective actions. A contamination investigation is more useful when it identifies where the process failed rather than assigning blame to an individual.
Document the full chain of evidence in the laboratory information system or controlled worksheet. Required fields may include the flag category, microscopy results, subculture observations, identification method, referral decision, report wording, communication log and final disposition. In a NATA-accredited environment, these records help demonstrate that the process is controlled, traceable and reviewed under the laboratory’s ISO 15189 quality framework.
Personnel competency should cover reading a positive MGIT event, recognising mixed growth, selecting the correct biosafety control, entering a preliminary report and escalating a suspected TB result. Competency assessment can use observed practice, case-based interpretation and periodic review of discrepant results. The GLI Quality Tool’s phased roadmap and Quality Systems Essentials provide a useful structure for linking this work to personnel, equipment, documentation, assessment and continual improvement.
Adapt the workflow to Australian services
Australian laboratories often operate across a hub-and-spoke model. A specimen processed in Perth may require referral to a specialist service for complex identification, while a regional service near Cairns or Alice Springs may need packaging and transport arrangements that account for distance, weather and courier schedules. The algorithm should include a contact list, referral forms, packaging requirements and a clear plan for weekends and public holidays.
Procurement is part of result reliability. Changes in MGIT tubes, supplements, decontamination reagents, molecular kits or culture media should trigger documented verification before routine use. Local purchasing teams may source products through Australian distributors, state contracts or international suppliers, so expiry dates, cold-chain conditions, lot traceability and back-order risks need review. A structured vendor evaluation method supports defensible decisions when a preferred reagent is unavailable.
The reporting algorithm should be tested with realistic cases from the service: a smear-positive sputum with a clean MGIT, an early flagged tube with Gram-negative contamination, an NTM isolate from a bronchoscopy, and a contaminated specimen from a remote collection site. Run these cases through the laboratory information system and after-hours escalation process. Confirm that the final report reaches the clinician, the public health team and the reference laboratory without relying on informal email chains.
| MGIT finding | Immediate laboratory action | Suggested report status | Escalation |
|---|---|---|---|
| Positive signal, acid-fast bacilli detected, no evident contamination | Confirm identity with a validated method and preserve the culture | Mycobacterial growth detected; identification pending | Notify urgently if TB is suspected clinically |
| Positive signal with bacterial or fungal overgrowth | Perform approved contamination assessment and determine whether recovery is possible | Culture affected by contamination; identification may be limited | Discuss repeat specimen or referral |
| Acid-fast bacilli and mixed bacterial growth | Treat as potentially mixed culture; retain material and refer if needed | Mycobacterial growth detected; mixed growth present | Escalate for confirmation and susceptibility testing |
| Positive signal, smear negative | Check controls, review timing and perform validated follow-up testing | Positive culture signal; organism identification pending | Escalate if the specimen is clinically urgent |
| Suspected M. tuberculosis complex | Confirm with validated identification and initiate susceptibility pathway | Confirmed or presumptive TB, according to evidence | Immediate clinician and public health communication |
| Instrument, tube or process failure | Quarantine affected material, investigate and repeat or refer | Test invalid or unable to be interpreted | Open a nonconformance and assess related specimens |
Place the algorithm beside the MGIT workstation in a controlled document, with version number, approval date and review owner. Link each decision to the relevant SOP, form and reporting template. Regular review after incidents, new equipment, changed reagents or updated state requirements will keep the workflow usable rather than merely compliant.
Use the GLI Quality Tool to map this algorithm across the four quality-improvement phases, convert each decision into a practical checklist, and assign evidence for staff training, equipment control, document management and corrective action. A well-maintained pathway turns an ambiguous contamination flag into a safe, timely and clinically meaningful result for Australian TB services.